Back to Top
Go Back
Journal Photo for Schizophrenia Research
Peer reviewed only Open Access

Schizophrenia Research (SR)

Publisher : Elsevier B.V.
Biological Psychiatry Psychiatry Mental Health
e-ISSN 1573-2509
p-ISSN 0920-9964
Issue Frequency Monthly
Impact Factor 3.6
Est. Year 1988
Mobile 31204853911
Language English
APC YES
Impact Factor Assignee Google Scholar
Email nlinfo@sciencedirect.com

Journal Descriptions

An International Multidisciplinary Journal of the Schizophrenia International Research Society As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership! Schizophrenia Research's time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue. The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia. Manuscripts with a focus on cognition in schizophrenia can be submitted to the journal?s open access companion title, Schizophrenia Research: Cognition.

Schizophrenia Research (SR) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Biological Psychiatry, Psychiatry, Mental Health, Psychology, Behavioral Neuroscience, Neurology, Multidisciplinary , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0920-9964, E-ISSN: 1573-2509, Established: 1988, Impact Factor: 3.6
  • Does Not Provide Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of SR

Peer Briken October, 2022
Aimed to determine whether there are differential effects of 3 different atypical antipsychotics when administered to manage patients with schizophrenia with marked hostility. Zotepine, olan...
Edward T. Bullmore March, 2010
Background Recent genetic results have indicated that the two major, classically distinct forms of psychosis – schizophrenia and bipolar disorder – may share causative factors in common...
Edward T. Bullmore March, 2009
The objective of the study was to identify whether there are consistent regional white matter changes in schizophrenia. A systematic search was conducted for voxel-based diffusion tensor ima...
Peter B Jones July, 2016
Aims To investigate trajectories of negative symptoms during the first 12 months of treatment for first episode psychosis (FEP), their predictors and relationship to social recovery. Metho...
Peter B Jones December, 2024
We aimed to investigate long-term outcomes in psychotic major depression patients compared to schizophrenia and bipolar/manic psychosis patients, in an incidence sample, while accounting for...
Peter B Jones October, 2017
The neurodevelopmental hypothesis of schizophrenia proposes that impaired brain development is a cause of the illness. Early motor developmental milestones, such as learning to walk, are pre...
Peter B Jones November, 2017
A need for a brief, easy to complete self-report questionnaire to detect people at ultra-high risk for psychosis (UHR) in busy clinical settings has been recognised. Our aim was to explore w...
Peter B Jones September, 2018
Objective To describe the characteristics of individuals with early sustained recovery following first episode psychosis. Methods Individuals with a first episode psychosis were followed-...
Peter B Jones February, 2019
Background: The role of insight dimensions – illness recognition (IR), symptoms relabelling (SR), treatment compliance (TC) - in suicide risk in first-episode psychosis (FEP) remains unc...
Peter B Jones February, 2019
Background Previous evidence suggests that delusional disorder has a later onset and better functional outcomes compared to schizophrenia. However, studies have not examined longitudinal ou...